According to a release Friday from the U.S. Food and Drug Administration, a voluntary recall has been implemented for several lots of EpiPen and EpiPen Jr Auto-Injectors distributed by Mylan Specialty and manufactured by Meridian Medical Technologies.

The recall of the emergency allergy treatment devices is due to the potential the injectors may contain defective parts that could cause a failure of the device to activate.

The FDA said  the number of of reported failures is small but the recall was implemented because of the potential life-threatening risk if there is a failure during a severe allergic reaction.

The FDA advises the public to keep and use their current EpiPens if needed until they receive their replacement.

If your EpiPen is from any of the lots listed below, contact Mylan at 800-796-9526 or customer.service@mylan.com.

The FDA advised there are currently 13 lots of EpiPens identified that are impacted by the U.S. recall. They were distributed between December 17, 2015 and July 1, 2016.

EpiPens covered by the recall:
Product/Dosage                               NDC Number            Lot Number           Expiration Date


EpiPen Jr Auto-Injector, 0.15 mg          49502-501-02          5GN767                      April 2017
EpiPen Jr Auto-Injector, 0.15 mg          49502-501-02          5GN773                      April 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         5GM631                     April 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         5GM640                     April 2017
EpiPen Jr Auto-Injector, 0.15 mg         49502-501-02          6GN215                      September 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         6GM082                     September 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         6GM072                     September 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         6GM081                     September 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         6GM088                     October 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         6GM199                     October 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         6GM091                     October 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         6GM198                     October 2017
EpiPen Auto-Injector, 0.3 mg               49502-500-02         6GM087                     October 2017

The FDA reminds the public you should always seek emergency medical help immediately after using your EpiPen, especially if the device did not activate.
The FDA asks health care professionals and consumers to report any adverse reactions or device malfunctions to their MedWatch program by:

Completing and submitting the report online at www.fda.gov/medwatch/report.htm, or
Downloading and completing the form, then submitting it via fax at 800-FDA-0178.

Facebook Comments